Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126779444 | 12677944 | 4 | F | 201408 | 20160916 | 20160823 | 20160922 | EXP | CA-ALEXION-A201606092 | ALEXION | 61.72 | YR | F | Y | 56.00000 | KG | 20160922 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126779444 | 12677944 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, QW | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | ||||||
| 126779444 | 12677944 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, Q2W | AE7317B04 | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
| 126779444 | 12677944 | 3 | C | PREVACID | LANSOPRAZOLE | 1 | Oral | 30 MG, QD | 0 | 30 | MG | QD | |||||||
| 126779444 | 12677944 | 4 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0.1 MG, QD | 0 | .1 | MG | QD | |||||||
| 126779444 | 12677944 | 5 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 126779444 | 12677944 | 6 | C | RISPERDAL | RISPERIDONE | 1 | Oral | 0.5 MG QD AND 1.0 MG QD | 0 | ||||||||||
| 126779444 | 12677944 | 7 | C | DILANTIN | PHENYTOIN | 1 | Oral | 300 MG, QD | 0 | 300 | MG | QD | |||||||
| 126779444 | 12677944 | 8 | C | DEPAKENE | VALPROIC ACID | 1 | Oral | 1000 MG, BID | 0 | 1000 | MG | BID | |||||||
| 126779444 | 12677944 | 9 | C | FRAGMIN | DALTEPARIN SODIUM | 1 | Subcutaneous | 5000 IU, QD | 0 | 5000 | IU | QD | |||||||
| 126779444 | 12677944 | 10 | C | COLACE | DOCUSATE SODIUM | 1 | Oral | 225 ML, PRN | 0 | 225 | ML | /yr | |||||||
| 126779444 | 12677944 | 11 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 975 MG, QID (PRN) | 0 | 975 | MG | QID | |||||||
| 126779444 | 12677944 | 12 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 126779444 | 12677944 | 13 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 126779444 | 12677944 | 14 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Oral | 1 MG, Q4H PRN | 0 | 1 | MG | Q4H | |||||||
| 126779444 | 12677944 | 15 | C | GRAVOL | DIMENHYDRINATE | 1 | Unknown | 50 MG, PRN 50 MG, 1 CO,Q 4-6 HRS | 0 | 50 | MG | /yr | |||||||
| 126779444 | 12677944 | 16 | C | ATIVAN | LORAZEPAM | 1 | Oral | 0.25 MG, PRN 1/2 CO | 0 | .25 | MG | /yr | |||||||
| 126779444 | 12677944 | 17 | C | SENOKOT | SENNOSIDES | 1 | Unknown | 8.6 MG, QD, PRN, 1-2 TAB | 0 | 8.6 | MG | TABLET | QD | ||||||
| 126779444 | 12677944 | 18 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | Oral | 500 MG, UNK | 0 | 500 | MG | ||||||||
| 126779444 | 12677944 | 19 | C | COTAZYM ECS /00150201/ | 2 | Unknown | 1 CAP, PRN | 0 | CAPSULE | /yr |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126779444 | 12677944 | 1 | Haemolytic uraemic syndrome |
| 126779444 | 12677944 | 3 | Prophylaxis |
| 126779444 | 12677944 | 4 | Hypothyroidism |
| 126779444 | 12677944 | 6 | Schizophrenia |
| 126779444 | 12677944 | 7 | Prophylaxis |
| 126779444 | 12677944 | 8 | Prophylaxis |
| 126779444 | 12677944 | 9 | Prophylaxis |
| 126779444 | 12677944 | 10 | Constipation |
| 126779444 | 12677944 | 11 | Pain |
| 126779444 | 12677944 | 12 | Pyrexia |
| 126779444 | 12677944 | 13 | Headache |
| 126779444 | 12677944 | 14 | Pain |
| 126779444 | 12677944 | 15 | Nausea |
| 126779444 | 12677944 | 16 | Insomnia |
| 126779444 | 12677944 | 17 | Constipation |
| 126779444 | 12677944 | 18 | Product used for unknown indication |
| 126779444 | 12677944 | 19 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126779444 | 12677944 | OT |
| 126779444 | 12677944 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126779444 | 12677944 | Abasia | |
| 126779444 | 12677944 | Asthenia | |
| 126779444 | 12677944 | Balance disorder | |
| 126779444 | 12677944 | Confusional state | |
| 126779444 | 12677944 | Cyanosis | |
| 126779444 | 12677944 | Decubitus ulcer | |
| 126779444 | 12677944 | Delirium | |
| 126779444 | 12677944 | Disorientation | |
| 126779444 | 12677944 | Fall | |
| 126779444 | 12677944 | Fatigue | |
| 126779444 | 12677944 | Inappropriate schedule of drug administration | |
| 126779444 | 12677944 | Mobility decreased | |
| 126779444 | 12677944 | Oxygen saturation decreased | |
| 126779444 | 12677944 | Peripheral swelling | |
| 126779444 | 12677944 | Pneumonia | |
| 126779444 | 12677944 | Poor venous access | |
| 126779444 | 12677944 | Somnolence | |
| 126779444 | 12677944 | Vein disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126779444 | 12677944 | 1 | 20140516 | 20140605 | 0 | |
| 126779444 | 12677944 | 2 | 20140612 | 0 | ||
| 126779444 | 12677944 | 4 | 2000 | 0 | ||
| 126779444 | 12677944 | 5 | 201501 | 0 | ||
| 126779444 | 12677944 | 6 | 2000 | 0 | ||
| 126779444 | 12677944 | 7 | 201405 | 0 | ||
| 126779444 | 12677944 | 8 | 201405 | 0 | ||
| 126779444 | 12677944 | 9 | 201405 | 0 | ||
| 126779444 | 12677944 | 14 | 201406 | 0 | ||
| 126779444 | 12677944 | 15 | 201405 | 0 | ||
| 126779444 | 12677944 | 16 | 201405 | 0 | ||
| 126779444 | 12677944 | 17 | 201406 | 0 | ||
| 126779444 | 12677944 | 18 | 201406 | 0 | ||
| 126779444 | 12677944 | 19 | 201406 | 0 |